Lv3
340 积分 2023-11-27 加入
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
20天前
已完结
Progress in preventing non-ventilator-associated hospital-acquired pneumonia
20天前
已完结
Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study
1个月前
已完结
2015 ESC Guidelines on the management of infective endocarditis: a big step forward for an old disease
2个月前
已完结
Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B
4个月前
已完结
Comparison of Hepatitis B e Antigen Clearance Rates between Tenofovir Alafenamide and Entecavir in Treatment-Naive Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients over 48–96 Weeks: A Retrospective Cohort Study
4个月前
已完结
Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B
4个月前
已完结
Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
6个月前
已完结
Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B
8个月前
已完结
Comparison of HBeAg clearance rates between tenofovir alafenamide and entecavir in treatment-naive HBeAg positive chronic hepatitis B patients over 48 to 96 weeks: A retrospective cohort study
8个月前
已关闭
皖公网安备34019202002308
